NCT03292354View on ClinicalTrials.gov

Personalization of CM Injection Protocols in Coronary Computed Tomographic Angiography

NACompletedINTERVENTIONAL
Enrollment

327

Participants

Timeline

Start Date

April 11, 2017

Primary Completion Date

September 14, 2018

Study Completion Date

September 14, 2018

Conditions
Coronary Artery CalcificationCardiac Disease
Interventions
OTHER

Contrast media administration

All patients will receive contrast media with a concentration of 300 mg I/mL (Iopromide 300). The flowrate and volume will be calculated with help of the different formulas belonging to the three different arms.

Trial Locations (1)

6202AZ

Maastricht University Medical Center, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT03292354 - Personalization of CM Injection Protocols in Coronary Computed Tomographic Angiography | Biotech Hunter | Biotech Hunter